The hypoxic response is an ancient stress response triggered by low ambient
oxygen (O2) (ref. 1) and controlled by
hypoxia-inducible transcription factor-1 (HIF-1), whose alpha subunit is rapidly degraded under normoxia but stabilized when O2-dependent
prolyl hydroxylases (PHDs) that target its O2-dependent degradation domain are inhibited. Thus, the amount of HIF-1alpha, which controls genes involved in energy metabolism and angiogenesis, is regulated post-translationally. Another ancient stress response is the innate immune response, regulated by several
transcription factors, among which
NF-kappaB plays a central role.
NF-kappaB activation is controlled by IkappaB
kinases (IKK), mainly
IKK-beta, needed for phosphorylation-induced degradation of IkappaB inhibitors in response to
infection and
inflammation.
IKK-beta is modestly activated in hypoxic cell cultures when PHDs that attenuate its activation are inhibited. However, defining the relationship between
NF-kappaB and HIF-1alpha has proven elusive. Using in vitro systems, it was reported that HIF-1alpha activates
NF-kappaB, that
NF-kappaB controls HIF-1alpha transcription and that HIF-1alpha activation may be concurrent with inhibition of
NF-kappaB. Here we show, with the use of mice lacking
IKK-beta in different cell types, that
NF-kappaB is a critical transcriptional activator of HIF-1alpha and that basal
NF-kappaB activity is required for HIF-1alpha
protein accumulation under
hypoxia in cultured cells and in the liver and brain of hypoxic animals.
IKK-beta deficiency results in defective induction of HIF-1alpha target genes including
vascular endothelial growth factor.
IKK-beta is also essential for HIF-1alpha accumulation in macrophages experiencing a
bacterial infection. Hence,
IKK-beta is an important physiological contributor to the hypoxic response, linking it to innate immunity and
inflammation.